Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Understanding the Seven Core Elements of an Effective Healthcare Compliance Program

Client Alert
January 22, 2026

The Patient Protection and Affordable Care Act (“ACA”) mandates that medical providers, as a condition of enrollment in Medicare, Medicaid, and the Children’s Health Insurance Program (“CHIP”), establish a compliance program.[1] The ACA also stipulates that the Department of Health and Human Services (“HHS”) and the Office of Inspector General (“OIG”) shall establish the core elements of a required compliance program.

There are seven main elements of an effective compliance program laid out by the HHS and OIG in the General Compliance Program Guidance (“GCPG”).

1. Written Policies and Procedures

Compliance requires all employees to understand their roles and responsibilities within the practice. Having written policies, such as a code of conduct, documentation requirements, and the processes to maintain compliance with Federal and State laws, allows expectations to be clearly communicated.    

The OIG recommends that written policies be easily accessible and comprehensible for individuals to refer to. In addition, policies should be kept up-to-date and revised when applicable laws change. Procedures on billing, coding, sales and marketing, quality of care, patient incentives, and arrangements with other healthcare providers should be included within written policies.      

2. Compliance Leadership and Oversight

The OIG states that “boards and senior leadership are vital to effective compliance programs,” especially when working to create a culture of compliance within a company.

Best practices for creating effective compliance oversight are appointing a compliance officer who has the authority and resources to ensure the success of a compliance program, as well as a compliance committee that supports the compliance officer.

3. Training and Education

Entities should have education and training programs for compliance, focusing on risk areas for the company or any issues discovered in an audit. These areas can range from billing and coding to interactions with other physicians.

Some topics the OIG recommends for employee training are the commitment to complying with Federal and State laws, the identity and role of the compliance officer, the importance of open communication with the compliance officer, and the various ways individuals can raise compliance questions and concerns with the compliance officer.

4. Effective Lines of Communication with the Compliance Officer and Disclosure Programs

Effective compliance programs encourage communication between employees, the board, and the compliance officer.

Best practices for creating effective lines of communication are informing staff about how and when the compliance officer can be reached directly and encouraging staff to bring any compliance questions to the compliance officer as soon as possible.  

In addition to making communication a priority, entities should create confidentiality and non-retaliation policies and implement an anonymous reporting option to encourage quick reporting. The OIG recommends logging all communication surrounding disclosure of compliance concerns or violations.    

5. Enforcing Standards: Consequences and Incentives

Both consequences and incentives are important for compliance program enforcement. Consequences for non-compliance can either be educational when a staff member was neglectful or can include sanctions if a staff member intentionally committed a compliance violation.

The OIG recommends that incentives be given for excellent compliance performance or contribution to the compliance program. Incentives can include additional compensation, significant recognition, or forms of encouragement.  

6. Risk Assessment, Auditing, and Monitoring

Risk assessments and audits allow for an entity to understand its compliance risk. Creating a plan for a risk assessment, conducting an internal audit, and utilizing data analytics allows for compliance efforts to be directed at areas where a company is most vulnerable to violations.

The OIG recommends that in addition to risk assessments, entities should monitor legal and regulatory changes to determine new areas of compliance risk. In addition, entities should maintain routine monitoring of ongoing risks, such as regular screening of State licensure certification databases.

7. Responding to Detected Offenses and Developing Corrective Initiatives

Compliance programs are designed to encourage compliance and detect areas of improvement. When areas of improvement are identified or a violation occurs, it is vital that entities have policies in place to respond to the concerns and take corrective action.  

Best practices are investigating all violations to determine what type of reporting or corrective action is required. In addition, the OIG recommends evaluating whether to engage outside counsel during the investigation. Counsel can help determine what reporting measures to take and what corrective action is needed. A thorough record of every violation investigation should be maintained.        

Implementing OIG Guidance

While the OIG considers the seven core components as essential for an effective compliance program, the OIG also recognizes that not every healthcare practice is the same. Entities may take different measures to accomplish each of the core elements. In addition, compliance programs may be adapted to fit a practice’s specific needs and can be adjusted based on the size of the practice. As such, the OIG also discusses compliance program adaptations for small and large entities in the GCPG and has published separate guidance for individual and small group physician practices.    

Developing or updating a compliance plan that mitigates risk for your practice is vital. We recommend engaging an attorney to draft or review your compliance program to ensure that it satisfies the OIG guidance and aligns with complex and changing healthcare regulations.

To learn more about the HHS-OIG General Compliance Program Guidance and how to develop a compliance plan for your practice, please contact BMD Health Law Group Member Jeana Singleton at jmsingleton@bmdllc.com or 330-253-2001.     

[1] Patient Protection and Affordable Care Act, Section 6401(a)(7).  

Health LawHealthcareAffordable Care ActJeana Singleton
Client Alert

Counselor, Social Workers, and Marriage and Family Therapist (CSWMFT) Board Rule Changes

March 29, 2024The Counselor, Social Workers, and Marriage and Family Therapist (CSWMFT) Board has proposed changes to the Ohio Administrative Code rules discussed below. The rules are scheduled for a public hearing on April 23, 2024, and public comments are due by this date. Please reach out to BMD Member Daphne Kackloudis for help preparing comments on these rules or for additional information.Client Alert

Latest Batch of Ohio Chemical Dependency Professionals Board Rules: What Providers Should Know

March 25, 2024The Ohio Chemical Dependency Professionals Board recently released several new rules and proposed amendments to existing rules over the past few months. A hearing for the new rules was held on February 16, 2024, but the Board has not yet finalized them.Client Alert

Now in Effect: DOL Final Rule on Classification of Independent Contractors

March 21, 2024Effective March 11, 2024, the U.S. Department of Labor (DOL) has adopted a new standard for the classification of employees versus independent contractors — a much anticipated update since the DOL issued its Final Rule on January 9, 2024, as previously discussed by BMD.  In brief, the Fair Labor Standards Act (FLSA) creates significant protections for workers related to minimum wage, overtime pay, and record-keeping requirements. That said, such protection only exists for employees. This can incentivize entities to classify workers as independent contractors; however, misclassification is risky and can be costly.Client Alert

Florida's Recent Ruling on Arbitration Clauses

March 15, 2024Florida’s recent ruling on arbitration clauses provides a crucial distinction in determining whether such clauses are void as against public policy and providers may have the opportunity to include arbitration clauses in their patient consent forms. On March 6, 2024, Florida’s Fourth District Court of Appeals reversed and remanded Florida’s Fifteenth Circuit Court ruling of Piero Palacios v. Sharnice Lawson. The Court of Appeals ruled that the parties’ arbitration agreement did not contradict the Legislature’s intent of Florida’s Medical Malpractice Act (the “MMA”), but rather reflects the parties’ choice to arbitrate claims entirely outside of the MMA’s framework. Therefore, the Court found that the agreement was not void as against public policy.Client Alert

Corporate Transparency Act Update 3/14/24

March 14, 2024On March 1, 2024, a federal district court in the Northern District of Alabama concluded that the Corporate Transparency Act (“CTA”) exceeded Congressional powers and enjoined the Department of the Treasury from enforcing the CTA against the plaintiffs. National Small Business United v. Yellen, No. 5:22-cv-01448 (N.D. Ala.). On March 11, 2024, the U.S. Department of Justice appealed the district court’s decision to the Eleventh Circuit Court of Appeals.
Older posts
Newer posts